MA29095B1 - Derives de chromane utiles comme antagonistes de la pompe a acide - Google Patents

Derives de chromane utiles comme antagonistes de la pompe a acide

Info

Publication number
MA29095B1
MA29095B1 MA29996A MA29996A MA29095B1 MA 29095 B1 MA29095 B1 MA 29095B1 MA 29996 A MA29996 A MA 29996A MA 29996 A MA29996 A MA 29996A MA 29095 B1 MA29095 B1 MA 29095B1
Authority
MA
Morocco
Prior art keywords
antagonists
derivatives useful
acid pump
chromane derivatives
chromane
Prior art date
Application number
MA29996A
Other languages
English (en)
French (fr)
Inventor
Madoka Jinno
Hirohisa Shimokawa
Tatsuya Yamagishi
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MA29095B1 publication Critical patent/MA29095B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA29996A 2004-12-17 2007-06-15 Derives de chromane utiles comme antagonistes de la pompe a acide MA29095B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63696304P 2004-12-17 2004-12-17
US69577205P 2005-06-29 2005-06-29

Publications (1)

Publication Number Publication Date
MA29095B1 true MA29095B1 (fr) 2007-12-03

Family

ID=35995811

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29996A MA29095B1 (fr) 2004-12-17 2007-06-15 Derives de chromane utiles comme antagonistes de la pompe a acide

Country Status (18)

Country Link
US (1) US20090291977A1 (de)
EP (1) EP1838309B1 (de)
JP (1) JP2008524199A (de)
KR (1) KR20070086294A (de)
AP (1) AP2007004023A0 (de)
AT (1) ATE405262T1 (de)
AU (1) AU2005315303A1 (de)
BR (1) BRPI0519598A2 (de)
CA (1) CA2591412A1 (de)
DE (1) DE602005009257D1 (de)
EA (1) EA011512B1 (de)
ES (1) ES2313444T3 (de)
IL (1) IL183602A0 (de)
MA (1) MA29095B1 (de)
MX (1) MX2007007010A (de)
NO (1) NO20072764L (de)
TN (1) TNSN07227A1 (de)
WO (1) WO2006064339A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007026218A2 (en) * 2005-09-01 2007-03-08 Pfizer Japan Inc. Chromane substituted 2-alkyl imidazopyridine derivatives and use thereof as acid pump antagonists
EP1996589A1 (de) * 2006-03-17 2008-12-03 RaQualia Pharma Inc Chromanderivate
WO2008059373A1 (en) * 2006-11-17 2008-05-22 Raqualia Pharma Inc. Imidazo [1, 2-a] pyrazine derivatives and their use as acid pump antagonists
KR102254957B1 (ko) 2013-11-22 2021-05-25 씨엘 바이오사이언시즈 엘엘씨 골다공증 치료 및 예방을 위한 가스트린 길항제(ｅｇ ｙｆ476, 네타제피드)
JP6315708B2 (ja) * 2015-06-22 2018-04-25 日本電信電話株式会社 リチウム空気二次電池、リチウム空気二次電池の製造方法及びリチウム空気二次電池を備えた装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
SE0102808D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab New compounds
RS20050377A (sr) * 2002-11-19 2007-11-15 Altana Pharma Ag., 8-supstituisani imidazopiridini

Also Published As

Publication number Publication date
AP2007004023A0 (en) 2007-06-30
IL183602A0 (en) 2007-09-20
EA011512B1 (ru) 2009-04-28
EA200701087A1 (ru) 2008-02-28
CA2591412A1 (en) 2006-06-22
ATE405262T1 (de) 2008-09-15
EP1838309B1 (de) 2008-08-20
US20090291977A1 (en) 2009-11-26
JP2008524199A (ja) 2008-07-10
BRPI0519598A2 (pt) 2009-03-10
EP1838309A1 (de) 2007-10-03
NO20072764L (no) 2007-07-03
TNSN07227A1 (fr) 2008-11-21
KR20070086294A (ko) 2007-08-27
DE602005009257D1 (de) 2008-10-02
AU2005315303A1 (en) 2006-06-22
WO2006064339A1 (en) 2006-06-22
ES2313444T3 (es) 2009-03-01
MX2007007010A (es) 2007-07-10

Similar Documents

Publication Publication Date Title
EP1976511A4 (de) Fluorierte arylamid-derivate
EP1948035A4 (de) Ventrikelpumpen-kupplung
EP2097111A4 (de) Heterodimere von glutaminsäure
DE602004030345D1 (de) Hyaluronsäure produzierende pflanze
DK1660431T3 (da) Phenoxyeddikesyrederivater
EP1968937A4 (de) DEAZAPURINANALOGA VON 1ý-AZA-L-NUKLEOSIDEN
DK1692242T3 (da) Viskoelastisk syre
FR2887593B1 (fr) Pompe amelioree
CL2013002895A1 (es) Compuestos derivados de 7,8-dihidro-5h-pteridin-6-ona, utiles como intermediarios en la sintesis de compuestos derivados de pteridinona (divisional de la solicitud 3123-2005).
EP1638626A4 (de) Pumpe
DE50212761D1 (de) Neuartige aminodicarbonsäurederivate
ATE383329T1 (de) Biaryloxymethylarenecarbonsäure
NL1029250A1 (nl) Benzimidazoloncarbonzuurderivaten.
EP1951231A4 (de) Camptothecin-derivate als chemoradiosensibilisierende mittel
ATE504556T1 (de) Herstellung von natriumdiformiat
MA29095B1 (fr) Derives de chromane utiles comme antagonistes de la pompe a acide
FR2910230B3 (fr) Methodes de biofertilisations pour ameliorer la stabilite des rendements de grandes cultures agronomiques.
EP1724287A4 (de) Hyaluronsäure/methotrexat-verbindung
DE602004014277D1 (de) Neue Dicarbonsäurederivate
DK1636288T3 (da) Tværbindende vandige polyurethandispersioner
FR2880540B1 (fr) Utilisation de derives de la purine comme inhibiteurs de la proteine hsp90
CY2011018I1 (el) Νεα κρυσταλλικη μορφη toy 8-kyan-1-kykλoπpoπyλ-7-(1s,6s-2,8-διαζαδικυκλο[4.3.0]εννεαν-8-υλ)-6-φθορο-1,4-διυδρο-4-οξο-3-κινολινο-καρβοξυλικου οξεος
DE60324703D1 (de) Barbitursäure derivaten.
EE00773U1 (et) Meetod vaba estsitalopraam-aluse v?i selle soola tootmiseks
FI20035067L (fi) Parveke tai vastaava